4 of the Highest-Growth Stocks in Biotech Today

Investing in the biotech industry can be a risky business. In most instances, the deck is stacked against a company succeeding. The vast majority of preclinical studies will fail to reach human trials, and there's no guarantee that a compound in clinical trials will reach pharmacy shelves. Not surprisingly, about 9 in 10 biotech stocks are currently losing money, and some simply may not survive.

However, if you do manage to pick a drug developer that brings exciting, game-changing therapies to market, your investment could increase many times over. A good example is Pharmacyclics, which is now under the ownership of AbbVie. Pharmacyclics wound up developing blood cancer drug Imbruvica, ultimately leading to a 45,700% price appreciation from its Great Recession lows to its buyout price just a few years later. Every investors' goal is to snag a rocket like Pharmacyclics, and the best way to do that is to look for high-growth companies in the biotech industry.

Based on Wall Street's consensus estimates, the following four biotech stocks offer some of the highest growth today.

Source: Fool.com